_484423

HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-A6NLF1, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-B2RMN5, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-E1P5P7, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-ENSG00000198646, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0003682, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0005625, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0005667, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0006260, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0006281, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0006310, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0006367, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0007420, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0007507, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0009725, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0030099, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0030374, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0030520, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0035097, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0042921, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0044255, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0044281, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0045944, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-GO-0060716, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-IPI00179071, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-NP_001229468.1, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-NP_054790.2, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-Q9NTZ9, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-Q9UH74, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-Q9UK86, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#RXR-REACT_111217, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-EBI-78670, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#UXR-Q14686

AIB3, Activating signal cointegrator 2, Amplified in breast cancer protein 3, Cancer-amplified transcriptional coactivator ASC-2, KIAA0181, NCOA6, Nuclear receptor coactivator RAP250, Nuclear receptor-activating protein, 250 kDa, Peroxisome proliferator-activated receptor-interacting protein, RAP250, TRBP, Thyroid hormone receptor-binding protein

HTTP://PATHWAYCOMMONS.ORG/PSI2BP#SF-EBI-1379595, HTTP://PATHWAYCOMMONS.ORG/PSI2BP#SF-EBI-1379597